Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,893
Total Claims
$2.7M
Drug Cost
446
Beneficiaries
$6,061
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+330%
Cost per patient vs peers
$6,061 vs $1,411 avg
+41%
Brand preference vs peers
14.9% vs 10.6% avg
Brand vs Generic
Brand: 3,384 claims · $2.2M
Generic: 19,272 claims · $490K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Diclofenac Epolamine | 534 | $360K |
| Lipase/Protease/Amylase | 294 | $344K |
| Sitagliptin Phosphate | 352 | $278K |
| Icosapent Ethyl | 413 | $174K |
| Empagliflozin | 120 | $125K |
| Denosumab | 61 | $105K |
| Tenofovir Alafenamide | 63 | $105K |
| Rsv Vacc, Pref A And Pref B/Pf | 272 | $85K |
| Dapagliflozin Propanediol | 108 | $81K |
| Linagliptin | 78 | $63K |
| Diclofenac Sodium | 135 | $51K |
| Icosapent Ethyl | 140 | $48K |
| Clemastine Fumarate | 12 | $46K |
| Finerenone | 44 | $44K |
| Cyclosporine | 54 | $39K |
Prescribing Profile
Patient Profile
71
Avg Age
51%
Female
0.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data